Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions.

n engl j med 376;21 nejm.org May 25, 2017 mary care practices for this demonstration, which qualifies as an Alternative Payment Model under the Medicare Access and CHIP Reauthorization Act (MACRA). Calls for fundamental payment and EHR reform are likely to trigger considerable discomfort and resistance. Many practice managers and payers and some clinician groups will mourn the loss of work documentation and process-based payment afforded by current EHRs and fee-for-service payment. Their substantial investment of time and money in the current systems and ability to benefit financially from them are not to be underestimated. These groups argue that paying for outcomes could be achieved with less disruption by simply grafting some value-based payments and penalties onto a fee-for-service model. This type of evolutionary approach is embodied in the MeritBased Incentive Payment option of MACRA. Although it is superficially appealing and encourages cost containment, this so-called pay-for-value plan relies even more heavily on EHR documentation and rewarding of achievement on process measures. It does little to reduce documentation burden or correct the misplaced emphases on care processes and service volume. Delivery from EHR purgatory is within our reach if we as a profession have the will to take more responsibility for outcomes. Not all outcomes are under our control, but focusing on those we can reasonably affect represents a genuine opportunity to restore meaning to our daily work and the social contract we have with our patients and society. Disclosure forms provided by the author are available at NEJM.org.

[1]  Allan H. Goroll,et al.  Fundamental Reform of Payment for Adult Primary Care: Comprehensive Payment for Comprehensive Care , 2007, Journal of General Internal Medicine.

[2]  D. Kansagara,et al.  The Effects of Pay-for-Performance Programs on Health, Health Care Use, and Processes of Care , 2017, Annals of Internal Medicine.

[3]  Allison P. Heath,et al.  Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.

[4]  Christine A. Sinsky,et al.  Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties , 2016, Annals of Internal Medicine.

[5]  Off the hamster wheel? Qualitative evaluation of a payment-linked patient-centered medical home (PCMH) pilot. , 2012, The Milbank quarterly.

[6]  P. Casali,et al.  Risks of the new EU Data Protection Regulation: an ESMO position paper endorsed by the European oncology community. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  L. F. A. Wessels,et al.  Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[9]  Bartha M Knoppers,et al.  A step forward for data protection and biomedical research , 2016, The Lancet.